v3.26.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2025
May 22, 2025
USD ($)
shares
$ / shares
Mar. 24, 2025
USD ($)
shares
$ / shares
Award Timing Disclosures [Line Items]      
Award Timing MNPI Disclosure
The Compensation Committee approves equity awards granted to the NEOs on or before the grant date. The Compensation Committee does not take material nonpublic information into account when determining the timing and terms of such awards. We have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.

As shown in the table below, in 2025, we awarded stock options to the NEOs during the period beginning four business days before the filing of a periodic report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on
Form 8-K disclosing material non-public information and ending one business day after the filing or furnishing of such report with the SEC.

NameGrant DateNumber of Securities Underlying the Award (#)
Exercise
Price
($)
Grant Date Fair Value
of the Award
($)
Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information (1)
Peter Beetham, Ph.D.
March 24, 2025
250,5002.20 457,666
0.00% (2)
Rory Riggs
May 22, 2025
39,3012.77 89,935
22.13% (3)
Greg Gocal, Ph.D.
March 24, 2025
119,5002.20 218,401
0.00% (2)
Jason Stokes, Esq.
March 24, 2025
56,5002.20 103,149
0.00% (2)
_________________________________________
(1) For completeness, all required Form 8-K filings during the covered periods have been assumed to include material non-public information.
(2) On March 27, 2025, we filed an amended Form 8-K reporting Dr. Beetham’s new annual base salary following his appointment as Interim CEO.
(3) As a non-employee director (following his resignation as Chief Executive Officer in February 2025), Mr. Riggs received the standard annual stock option grant to non-employee directors on the date of our 2025 Annual Meeting of Stockholders on May 22, 2025. We filed Forms 8-K on each of 5/23/2025 and 5/27/2025. The percentage change reflected in the table above represents the change in the closing market price of our Class A Common Stock from the trading day ending immediately prior to 5/27/2025 and the trading day beginning immediately following 5/27/2025. The percentage change in the closing market price of our Class A Common Stock from the trading day ending immediately prior to 5/23/2025 and the trading day beginning immediately following 5/23/2025 was 2.89%.
    
Award Timing Method
The Compensation Committee approves equity awards granted to the NEOs on or before the grant date. The Compensation Committee does not take material nonpublic information into account when determining the timing and terms of such awards. We have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.
    
Award Timing Predetermined false    
Award Timing MNPI Considered true    
Award Timing, How MNPI Considered We have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.    
MNPI Disclosure Timed for Compensation Value false    
Awards Close in Time to MNPI Disclosures, Table
NameGrant DateNumber of Securities Underlying the Award (#)
Exercise
Price
($)
Grant Date Fair Value
of the Award
($)
Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information (1)
Peter Beetham, Ph.D.
March 24, 2025
250,5002.20 457,666
0.00% (2)
Rory Riggs
May 22, 2025
39,3012.77 89,935
22.13% (3)
Greg Gocal, Ph.D.
March 24, 2025
119,5002.20 218,401
0.00% (2)
Jason Stokes, Esq.
March 24, 2025
56,5002.20 103,149
0.00% (2)
_________________________________________
(1) For completeness, all required Form 8-K filings during the covered periods have been assumed to include material non-public information.
(2) On March 27, 2025, we filed an amended Form 8-K reporting Dr. Beetham’s new annual base salary following his appointment as Interim CEO.
(3) As a non-employee director (following his resignation as Chief Executive Officer in February 2025), Mr. Riggs received the standard annual stock option grant to non-employee directors on the date of our 2025 Annual Meeting of Stockholders on May 22, 2025. We filed Forms 8-K on each of 5/23/2025 and 5/27/2025. The percentage change reflected in the table above represents the change in the closing market price of our Class A Common Stock from the trading day ending immediately prior to 5/27/2025 and the trading day beginning immediately following 5/27/2025. The percentage change in the closing market price of our Class A Common Stock from the trading day ending immediately prior to 5/23/2025 and the trading day beginning immediately following 5/23/2025 was 2.89%.
    
Peter Beetham [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Peter Beetham, Ph.D.
Underlying Securities | shares     250,500
Exercise Price | $ / shares     $ 2.20
Fair Value as of Grant Date | $     $ 457,666
Underlying Security Market Price Change     0.0000
Rory Riggs [Member]      
Awards Close in Time to MNPI Disclosures      
Name   Rory Riggs  
Underlying Securities | shares   39,301  
Exercise Price | $ / shares   $ 2.77  
Fair Value as of Grant Date | $   $ 89,935  
Underlying Security Market Price Change   0.2213  
Greg Gocal, Ph.D. [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Greg Gocal, Ph.D.
Underlying Securities | shares     119,500
Exercise Price | $ / shares     $ 2.20
Fair Value as of Grant Date | $     $ 218,401
Underlying Security Market Price Change     0.0000
Jason Stokes, Esq. [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Jason Stokes, Esq.
Underlying Securities | shares     56,500
Exercise Price | $ / shares     $ 2.20
Fair Value as of Grant Date | $     $ 103,149
Underlying Security Market Price Change     0.0000